PPARA and Alzheimer disease: Lately, the involvement of PPAR ligands in neurodegenerative disorders, such as Alzheimer’s disease (AD), multiple sclerosis, amyotrophic lateral sclerosis (ALS), and Parkinson’s disease (PD) was well established [6,7,8].